Skip to main content

The U.S. Food and Drug Administration on Sept. 22 authorized a booster dose of the Pfizer-BioNTech COVID-19 vaccine for those aged 65 and older and some high-risk Americans, paving the way for a quick rollout of the shots. Bryan Wood reports.

Reuters